Nurse Practitioner · Corpus Christi, TX
NPI
1770299034
Since 2023
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4302 Ayers St
Corpus Christi, TX, 78415
Phone (361) 400-7700
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.8M
2,959 prescriptions
Company payments, 2025
$3,708
From 16 companies
Medicare prescription drug claims, 2024
In 2024, the drug Krystal A Perez Franco prescribed most often to Medicare patients was Leflunomide, with 543 prescriptions and refills. In total Krystal A Perez Franco wrote 2,959 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-28.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Leflunomide Generic | 543 | 759 | 136 | $14K |
| Hydroxychloroquine Sulfate Generic | 463 | 587 | 109 | $8,369 |
| Prednisone Generic | 414 | 460 | 128 | $1,309 |
| Methotrexate Methotrexate Sodium | 326 | 386 | 73 | $2,913 |
| Folic Acid Generic | 130 | 194 | 30 | $587 |
| Sulfasalazine Generic | 114 | 172 | 31 | $1,543 |
| Enbrel Sureclick Etanercept | 69 | 69 | 14 | $511K |
| Rinvoq Upadacitinib | 63 | 63 | 11 | $451K |
| Alendronate Sodium Generic | 59 | 103 | 22 | $301 |
| Cosentyx Sensoready Pen Secukinumab | 55 | 55 | Under 11 | $407K |
| Duloxetine Hcl Generic | 49 | 57 | Under 11 | $592 |
| Triamcinolone Acetonide Generic | 48 | 52 | 23 | $320 |
| Celecoxib Generic | 44 | 48 | 13 | $664 |
| Humira(Cf) Pen Adalimumab | 43 | 43 | Under 11 | $294K |
| Cyclobenzaprine Hcl Generic | 40 | 40 | Under 11 | $339 |
Brand drugs: 488 claims; generic drugs: 2,471 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Krystal A Perez Franco $3,708 ($3,708 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $770.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 41 | $770 |
| Abbvie Inc. ABBV | 40 | $642 |
| Janssen Biotech, Inc. JNJ | 14 | $535 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $353 |
| ANI Pharmaceuticals, Inc. ANIP | 20 | $295 |
| UCB, Inc. UCB.BR | 7 | $264 |
| Aurinia Pharma U.S., Inc. AUPH | 29 | $190 |
| GlaxoSmithKline, LLC. GSK | 4 | $175 |
| Pfizer Inc. PFE | 6 | $111 |
| Radius Health, Inc. | 5 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.